Published in Appl Environ Microbiol on July 01, 1978
Microbial acetyl conjugation of T-2 toxin and its derivatives. Appl Environ Microbiol (1980) 0.86
Biotransformation and detoxification of T-2 toxin by soil and freshwater bacteria. Appl Environ Microbiol (1989) 0.83
Production of 3-acetoxyscirpene-4,15-diol from anguidine (4,15-diacetoxyscirpene-3-ol) by Fusarium oxysporum f.sp. vasinfectum. Appl Environ Microbiol (1979) 0.80
Trichodermin esterase activity and trichodermin resistance in Mucor racemosus. Antimicrob Agents Chemother (1986) 0.79
Modeling of human CCR5 as target for HIV-I and virtual screening with marine therapeutic compounds. Bioinformation (2008) 0.78
Microbial transformation of macrocyclic trichothecenes. Appl Environ Microbiol (1983) 0.75
FRESH ISOLATES OF ACTINOMYCETES IN WHICH THE PRESENCE OF SPOROGENOUS AERIAL MYCELIA IS A FLUCTUATING CHARACTERISTIC. J Bacteriol (1949) 3.44
Biological modification of trichothecene mycotoxins: acetylation and deacetylation of deoxynivalenols by Fusarium spp. Appl Microbiol (1975) 2.05
In vitro metabolism of T-2 toxin. Appl Microbiol (1974) 2.02
Mycotoxins: occurrence, chemistry, biological activity. Lloydia (1975) 1.66
The cytotoxicity of some transformation products of diacetoxyscirpenol. Biochem Pharmacol (1969) 1.49
Enzymic inactivation of trichothecin and crotocin. Nature (1961) 1.39
Comparative studies on microbial and chemical modifications of trichothecene mycotoxins. Appl Microbiol (1975) 1.09
Worldwide epidemiology of human adenovirus infections. Am J Epidemiol (1983) 3.45
Detection of dengue virus RNA in patients after primary or secondary dengue infection by using the TaqMan automated amplification system. J Clin Microbiol (1999) 2.96
Imported lassa fever in Germany: molecular characterization of a new lassa virus strain. Emerg Infect Dis (2000) 2.69
IgM antibodies to Epstein-Barr virus in infectious mononucleosis. Arch Gesamte Virusforsch (1972) 2.47
Detection of IgM antibodies to cytomegalovirus (CMV) using an enzyme-labelled antigen (ELA). J Gen Virol (1980) 2.13
Determination of different cytomegalovirus immunoglobulins (IgG, IgA, IgM) by immunofluorescence. Arch Gesamte Virusforsch (1972) 2.04
Tomographic 3D reconstruction of quick-frozen, Ca2+-activated contracting insect flight muscle. Cell (1999) 1.85
Solid-phase enzyme immunoassay for immunoglobulin M antibodies to cytomegalovirus. J Clin Microbiol (1977) 1.75
Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. Am J Trop Med Hyg (1996) 1.70
Detection of Lassa virus RNA in specimens from patients with Lassa fever by using the polymerase chain reaction. J Clin Microbiol (1990) 1.61
Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. J Cell Sci (2000) 1.60
The prevalence of antibodies to HIV-1 and HIV-2 in onchocerciasis-endemic rural areas in southern Benin. AIDS (1993) 1.44
Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum. J Infect Dis (2001) 1.40
IgM antibodies to cytomegalovirus during pregnancy. Arch Virol (1977) 1.38
X-ray diffraction indicates that active cross-bridges bind to actin target zones in insect flight muscle. Biophys J (1998) 1.38
Arthroscopic treatment of septic joints: prognostic factors. Arch Orthop Trauma Surg (2002) 1.32
Cimetidine for anastomotic ulcers after partial gastrectomy. A randomized controlled trial. N Engl J Med (1979) 1.32
Improved detection of virus-specific IgM antibodies. Elimination of non-specific IgM binding. J Gen Virol (1978) 1.31
Clinical evaluation of patients with infectious mononucleosis and development of antibodies to the R component of the Epstein-Barr virus-induced early antigen complex. Am J Med (1975) 1.30
Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction. Circulation (1982) 1.27
Purification and characterization of West Nile virus nucleoside triphosphatase (NTPase)/helicase: evidence for dissociation of the NTPase and helicase activities of the enzyme. J Virol (2001) 1.25
Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein. J Virol (2000) 1.24
Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies by a simple recombinant immunoblot assay for field use. J Clin Microbiol (1998) 1.24
Antibodies to human cytomegalovirus structural polypeptides during primary infection. J Virol Methods (1988) 1.23
Effect of smoking on duodenal ulcer healing with cimetidine and oxmetidine. Gut (1982) 1.22
Cross-reactivity in flavivirus serology: new implications of an old finding? Med Microbiol Immunol (2002) 1.21
Seroepidemiology of human immunodeficiency virus in Africa. Br Med J (Clin Res Ed) (1986) 1.20
A haemorrhagic fever from the Côte d'Ivoire. Lancet (1999) 1.17
Permeability of human HT-29/B6 colonic epithelium as a function of apoptosis. J Physiol (2001) 1.17
Diagnosis of human cytomegalovirus-induced retinitis in human immunodeficiency virus type 1-infected subjects by using the polymerase chain reaction. J Clin Microbiol (1991) 1.16
CD34+ hematopoietic progenitor cells are not a major reservoir of the human immunodeficiency virus. Blood (1990) 1.15
Duodenal biopsies of HIV-infected patients with diarrhoea exhibit epithelial barrier defects but no active secretion. AIDS (1998) 1.14
Detection of immunoglobulin M antibody to Epstein-Barr virus by use of an enzyme-labeled antigen. J Clin Microbiol (1982) 1.13
Epitope mapping of the Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies. Arch Virol (1989) 1.12
Mechanisms of diarrhea in the interleukin-2-deficient mouse model of colonic inflammation. Am J Physiol Gastrointest Liver Physiol (2004) 1.12
Follicular dendritic cells retain HIV-1 particles on their plasma membrane, but are not productively infected in asymptomatic patients with follicular hyperplasia. J Immunol (1994) 1.09
Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe. Euro Surveill (2005) 1.08
Antitumor activity of 15-acetoxyscirpen-3,4-diol. J Antibiot (Tokyo) (1978) 1.08
Acute Epstein-Barr virus infections in children. Med Microbiol Immunol (1972) 1.08
Simple detection of fluorescent stained IgM in sucrose gradients: demonstration of virus-specific IgM. Intervirology (1974) 1.04
Rift Valley fever in Nigeria: infections in domestic animals. Rev Sci Tech (1996) 1.04
The infrared receptor of Melanophila acuminata De Geer (Coleoptera: Buprestidae): ultrastructural study of a unique insect thermoreceptor and its possible descent from a hair mechanoreceptor. Tissue Cell (1995) 1.03
A novel model for the study of the therapy of flavivirus infections using the Modoc virus. Virology (2001) 1.02
Detection of HIV-1 DNA in different subsets of human peripheral blood mononuclear cells using the polymerase chain reaction. Rapid communication. Arch Virol (1989) 1.01
An improved technique for the diagnosis of viral retinitis from samples of aqueous humor and vitreous. Graefes Arch Clin Exp Ophthalmol (1993) 1.00
Joint preserving surgery for osteonecrosis and osteochondral defects after chemotherapy in childhood. Klin Padiatr (2003) 0.99
Mechanisms of epithelial barrier impairment in HIV infection. Ann N Y Acad Sci (2000) 0.99
Cytomegalovirus as a frequent cause of Guillain-Barré syndrome. J Med Virol (1977) 0.99
Rapid method to detect rubella immunoglobulin M and immunoglobulin A antibodies. J Clin Microbiol (1975) 0.98
Cytomegalovirus myocarditis. Am Heart J (1980) 0.98
Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59. J Clin Invest (1995) 0.98
ATP-binding domain of NTPase/helicase as a target for hepatitis C antiviral therapy. Acta Biochim Pol (2000) 0.98
Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1. Glycobiology (2001) 0.97
Studies on the structure and regulation of the human hepatic interleukin-6 receptor. Eur J Biochem (1990) 0.96
Comparison of the neutralizing and ELISA antibody titres to human cytomegalovirus (HCMV) in human sera and in gamma globulin preparations. J Med Virol (1986) 0.96
Influence of cobalt on fermentative methylation. Appl Microbiol (1966) 0.96
Rift Valley fever in Nigeria: infections in humans. Rev Sci Tech (1996) 0.96
Human immune response to proteins of cytomegalovirus. Intervirology (1980) 0.96
Evaluation of the efficacy and tolerability of acarbose in patients with diabetes mellitus : a postmarketing surveillance study. Clin Drug Investig (2005) 0.95
RELATIONS OF HISTOLOGICAL STRUCTURE AND CLINICAL GROUPING TO THE PROGNOSIS OF CARCINOMATA OF THE BREAST AND UTERINE CERVIX. Ann Surg (1929) 0.94
Human Kupffer cells infected with HIV-1 in vivo. J Acquir Immune Defic Syndr (1993) 0.94
Epithelial barrier defects in HT-29/B6 colonic cell monolayers induced by tumor necrosis factor-alpha. Ann N Y Acad Sci (2000) 0.93
Sensitive method to detect non-complement-fixing antibodies to Epstein-Barr virus nuclear antigne. Int J Cancer (1975) 0.93
Detection of specific immunoglobulin M antibody to different flaviviruses by use of enzyme-labeled antigens. J Clin Microbiol (1984) 0.93
Identification of CCK-B/gastrin receptor splice variants in human peripheral blood mononuclear cells. Regul Pept (2001) 0.93
Structural modifications of anguidin and antitumor activities of its analogues. J Med Chem (1982) 0.92
Experimental infection of three Nigerian breeds of sheep with the Zinga strain of the Rift Valley Fever virus. Rev Elev Med Vet Pays Trop (1996) 0.92
[Mast cells in skin altered by psoriasis--before, during and after cignolin therapy]. Dermatol Wochenschr (1967) 0.92
[Cimetidine in the treatment of duodenal ulcer (author's transl)]. Dtsch Med Wochenschr (1978) 0.91
First outbreak of callitrichid hepatitis in Germany: genetic characterization of the causative lymphocytic choriomeningitis virus strains. Virology (2001) 0.91
Isolation of normal human follicular dendritic cells and CD4-independent in vitro infection by human immunodeficiency virus (HIV-1). Eur J Immunol (1991) 0.90
Calibration results obtained with Liulin-4 type dosimeters. Adv Space Res (2002) 0.89
Antibodies to ATLV/HTLV-1 in Africa. Med Microbiol Immunol (1984) 0.88
[Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study]. Arzneimittelforschung (1993) 0.88
Endocrine effects of Lycopus europaeus L. following oral application. Arzneimittelforschung (1994) 0.87
[Metabolism of the rabbit heart in situ during asphyxia and in post-asphyxial recovery]. Pflugers Arch (1970) 0.87
Detection of coronavirus-like particles in homosexual men with acquired immunodeficiency and related lymphadenopathy syndrome. Klin Wochenschr (1985) 0.87
Antitumor activity of kijanimicin. J Antibiot (Tokyo) (1983) 0.87
IL-1beta and TNF-alpha, but not IFN-alpha, IFN-gamma, IL-6 or IL-8, are secretory mediators in human distal colon. Cytokine (1998) 0.86
Nimodipine in traumatic subarachnoid haemorrhage: a re-analysis of the HIT I and HIT II trials. Acta Neurochir (Wien) (1996) 0.86
Hedamycin, a new antitumor antibiotic. I. Production, isolation, and characterization. Antimicrob Agents Chemother (Bethesda) (1966) 0.86
Afferent projections of infrared-sensitive sensilla in the beetle Melanophila acuminata (Coleoptera: Buprestidae). Cell Tissue Res (1999) 0.86
Inhibition of the helicase activity of HCV NTPase/helicase by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide-5 '-triphosphate (ribavirin-TP). Acta Biochim Pol (2001) 0.86
[Cytomegalovirus infection in the adult]. Dtsch Med Wochenschr (1973) 0.86
Abnormal B-cell response to T-cell-independent polyclonal B-cell activators in homosexuals presenting persistent generalized lymph node enlargement and HTLV-III antibodies. Diagn Immunol (1986) 0.85
The proteins of the Hepatitis C virus: their features and interactions with intracellular protein phosphorylation. Arch Virol (2003) 0.85
Antibodies to Lassa virus Z protein and nucleoprotein co-occur in human sera from Lassa fever endemic regions. Med Microbiol Immunol (2001) 0.85
Semisynthetic coumermycins. II. Preparation and properties of 3-(substituted benzamido)-4-hydroxy-8-methyl-7-[3-O-(5-methyl-2-pyrrolylcarbonyl)noviosyloxy] coumarins. J Antibiot (Tokyo) (1968) 0.85
Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene. Virology (2000) 0.85
Preparation of semisynthetic coumermycin A1 derivatives. 3. Aromatic and heteroaromatic derivatives of 3-amino-4-hydroxy-8-methyl-7-[3-O-(5-methyl-2-pyrrolylcarbonyl) noviosyloxy]coumarin. Antimicrob Agents Chemother (Bethesda) (1968) 0.84
Effect of the calcium antagonists nifedipine, nitrendipine, nimodipine and nisoldipine on oesophageal motility in man. Eur J Clin Pharmacol (1991) 0.84
[Cytokine secretion in whole blood of healthy subjects following oral administration of Urtica dioica L. plant extract]. Arzneimittelforschung (1996) 0.84
Cytomegalovirus strain differentiation by DNA restriction analysis. Oncology (1979) 0.84
A Belgian traveler who acquired yellow fever in the Gambia. Clin Infect Dis (2002) 0.84
Typing of Herpesvirus simplex hominis 1 and 2 by indirect immunofluorescence. Med Microbiol Immunol (1974) 0.84
Biochemical properties of a minimal functional domain with ATP-binding activity of the NTPase/helicase of hepatitis C virus. Eur J Biochem (1999) 0.84
[Anti-inflammatory effect of Urtica dioica folia extract in comparison to caffeic malic acid]. Arzneimittelforschung (1996) 0.83